Our clinicians have put together a unique treatment bundle to help you manage any common side effects you may experience
Future research: TRIUMPH phase 3 program Following the positive results from the NCT 04881760 study, Lilly is planning the TRIUMPH Phase 3 program, which will further test retatrutides impact on chronic weight management, obstructive sleep apnea, and knee osteoarthritis in people with obesity and overweight
No problem at all
These statements involve known and unknown risks, uncertainties and other factors which are not exhaustive
Aroda VR, Edelstein SL, Goldberg RB, Knowler WC, Marcovina SM, Orchard TJ, et al
Older-generation compounds have benefited from years of manufacturing optimization and increased competition, leading to much lower market prices